Royalty Pharma plcRPRXNASDAQ
LOADING
|||
PE Ratio: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-earnings ratio
Latest
13.24
↓ 78% below average
Average (9y)
60.04
Historical baseline
Range
High:404.10
Low:6.71
CAGR
-13.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 13.24 | +19.5% |
| 2023 | 11.08 | -97.3% |
| 2022 | 404.10 | +1415.0% |
| 2021 | 26.67 | +33.9% |
| 2020 | 19.92 | +196.9% |
| 2019 | 6.71 | -41.3% |
| 2018 | 11.44 | -12.2% |
| 2017 | 13.03 | -72.7% |
| 2016 | 47.73 | +2.7% |
| 2015 | 46.46 | - |